Shenzhen Kangtai Biological Products Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Q33
  • SHE: 300601
CNY
13.08
0.09 (0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
641.89
631.11
609.64
671.38
746.86
645.20
633.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
641.89
631.11
609.64
671.38
746.86
645.20
633.51
Raw Material Cost
248.30
248.10
198.14
267.26
227.34
235.08
201.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
29.76
29.50
30.16
30.13
29.25
29.49
31.04
Selling and Distribution Expenses
261.38
275.31
263.78
264.88
321.38
263.68
305.68
Other Expenses
3.51
2.88
6.29
6.27
11.90
6.31
13.68
Total Expenditure (Excl Depreciation)
574.57
581.69
554.95
624.98
696.95
591.33
675.05
Operating Profit (PBDIT) excl Other Income
67.30000000000001
49.400000000000006
54.699999999999996
46.4
49.900000000000006
53.9
-41.5
Other Income
11.29
13.37
34.98
22.68
37.65
28.96
27.57
Operating Profit (PBDIT)
131.32
169.26
176.37
135.86
105.75
160.10
-55.70
Interest
29.76
29.50
30.16
30.13
29.25
29.49
31.04
Exceptional Items
7.22
7.60
4.85
0.38
0.06
0.00
0.45
Gross Profit (PBDT)
393.59
383.02
411.50
404.12
519.51
410.12
432.01
Depreciation
107.42
107.42
105.79
105.79
103.64
103.64
98.23
Profit Before Tax
1.37
39.95
45.26
0.32
-27.09
26.97
-184.52
Tax
-12.75
6.35
24.17
-11.26
-42.31
4.58
-35.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.05
33.34
21.17
11.62
15.10
22.43
-149.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.05
33.34
21.17
11.62
15.10
22.43
-149.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.93
0.26
-0.08
-0.04
0.12
-0.05
-0.08
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.12
33.60
21.09
11.58
15.22
22.39
-149.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
9,643.00
9,665.05
9,631.74
9,610.59
9,598.95
9,683.54
9,661.12
Earnings per share (EPS)
0.02
0.03
0.02
0.01
0.01
0.02
-0.13
Diluted Earnings per share
0.02
0.03
0.02
0.01
0.01
0.02
-0.13
Operating Profit Margin (Excl OI)
1.96%
7.68%
5.84%
1.1%
-4.76%
4.26%
-28.65%
Gross Profit Margin
16.95%
23.35%
24.78%
15.81%
10.25%
20.24%
-13.62%
PAT Margin
2.66%
5.28%
3.47%
1.73%
2.02%
3.48%
-23.59%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.71% vs 3.53% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -58.04% vs 59.24% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -23.03% vs 10.25% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 1.02% vs -2.32% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Shenzhen Kangtai Biological Products Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
641.89
0
641.89
Other Operating Income
0.00
0.00
0.00
Total Operating income
641.89
0
641.89
Raw Material Cost
248.30
0
248.30
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
29.76
0
29.76
Selling and Distribution Expenses
261.38
0
261.38
Other Expenses
3.51
0.00
3.51
Total Expenditure (Excl Depreciation)
574.57
0
574.57
Operating Profit (PBDIT) excl Other Income
67.33
0.00
67.33
Other Income
11.29
0
11.29
Operating Profit (PBDIT)
131.32
0
131.32
Interest
29.76
0
29.76
Exceptional Items
7.22
0
7.22
Gross Profit (PBDT)
393.59
0
393.59
Depreciation
107.42
0
107.42
Profit Before Tax
1.37
0
1.37
Tax
-12.75
0
-12.75
Provisions and contingencies
0
0
0.00
Profit After Tax
17.05
0
17.05
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.05
0
17.05
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.93
0
-2.93
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.12
0
14.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
9,643.00
0
9,643.00
Earnings per share (EPS)
0.02
0
0.02
Diluted Earnings per share
0.02
0
0.02
Operating Profit Margin (Excl OI)
1.96%
0%
0.00
1.96%
Gross Profit Margin
16.95%
0%
0.00
16.95%
PAT Margin
2.66%
0%
0.00
2.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 64.19 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1.71% vs 3.53% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -14.06% vs -0.47% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.41 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -58.04% vs 59.24% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -7.24% vs -86.34% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.00 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -23.03% vs 10.25% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 76.21% vs -55.31% in Jun 2025

Quarterly - Interest
Interest 2.98 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1.02% vs -2.32% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1.71% vs -4.56% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.96%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025